搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Acyrthosiphon pisum secondary endosymbiont phage 1 Putative protein p15 (15) CSB-YP874587AKAV
CSB-EP874587AKAV
CSB-BP874587AKAV
CSB-MP874587AKAV
CSB-EP874587AKAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acyrthosiphon pisum secondary endosymbiont phage 1 Putative protein p8 (8) CSB-YP874588AKAV
CSB-EP874588AKAV
CSB-BP874588AKAV
CSB-MP874588AKAV
CSB-EP874588AKAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacteria phage Mu Probable tail fiber assembly protein (U) CSB-YP874589EDA
CSB-EP874589EDA
CSB-BP874589EDA
CSB-MP874589EDA
CSB-EP874589EDA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacteria phage Mu Protein gp42 (42), partial CSB-YP874590EDA
CSB-EP874590EDA
CSB-BP874590EDA
CSB-MP874590EDA
CSB-EP874590EDA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacteria phage Mu Protein gp27 (27) CSB-YP874591EDA
CSB-EP874591EDA
CSB-BP874591EDA
CSB-MP874591EDA
CSB-EP874591EDA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spinacia oleracea Chlorophyll a-b binding protein CSB-YP874592FKI
CSB-EP874592FKI
CSB-BP874592FKI
CSB-MP874592FKI
CSB-EP874592FKI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea Putative septum site-determining protein MinD (minD-A) CSB-YP874593NDAA
CSB-EP874593NDAA
CSB-BP874593NDAA
CSB-MP874593NDAA
CSB-EP874593NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nephroselmis olivacea Light-independent protochlorophyllide reductase subunit B (chlB), partial CSB-YP874594NDAA
CSB-EP874594NDAA
CSB-BP874594NDAA
CSB-MP874594NDAA
CSB-EP874594NDAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spermophilus pallidicauda Cytochrome b (MT-CYB), partial CSB-YP874595SLAW
CSB-EP874595SLAW
CSB-BP874595SLAW
CSB-MP874595SLAW
CSB-EP874595SLAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Photosystem I reaction center subunit II, cyanelle (psaD) CSB-YP874596DZX
CSB-EP874596DZX
CSB-BP874596DZX
CSB-MP874596DZX
CSB-EP874596DZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rana amurensis Cytochrome b (mt-cyb), partial CSB-YP874597REAL
CSB-EP874597REAL
CSB-BP874597REAL
CSB-MP874597REAL
CSB-EP874597REAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microtus miurus Cytochrome b (MT-CYB), partial CSB-YP874598MLAU
CSB-EP874598MLAU
CSB-BP874598MLAU
CSB-MP874598MLAU
CSB-EP874598MLAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gymnuromys roberti Cytochrome b (MT-CYB), partial CSB-YP874599GEAI
CSB-EP874599GEAI
CSB-BP874599GEAI
CSB-MP874599GEAI
CSB-EP874599GEAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brachyuromys ramirohitra Cytochrome b (MT-CYB), partial CSB-YP874600BGAJ
CSB-EP874600BGAJ
CSB-BP874600BGAJ
CSB-MP874600BGAJ
CSB-EP874600BGAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tragelaphus oryx Cytochrome b (MT-CYB), partial CSB-YP874601TPE
CSB-EP874601TPE
CSB-BP874601TPE
CSB-MP874601TPE
CSB-EP874601TPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Paralichthys olivaceus Cytochrome b (mt-cyb), partial CSB-YP874602ERT
CSB-EP874602ERT
CSB-BP874602ERT
CSB-MP874602ERT
CSB-EP874602ERT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan troglodytes NADH-ubiquinone oxidoreductase chain 3 (MT-ND3), partial CSB-YP874603EQV1
CSB-EP874603EQV1
CSB-BP874603EQV1
CSB-MP874603EQV1
CSB-EP874603EQV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan paniscus NADH-ubiquinone oxidoreductase chain 6 (MT-ND6), partial CSB-YP874604EQU1
CSB-EP874604EQU1
CSB-BP874604EQU1
CSB-MP874604EQU1
CSB-EP874604EQU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo pygmaeus NADH-ubiquinone oxidoreductase chain 2 (MT-ND2), partial CSB-YP874605EXP
CSB-EP874605EXP
CSB-BP874605EXP
CSB-MP874605EXP
CSB-EP874605EXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lampetra fluviatilis ATP synthase protein 8 (MT-ATP8), partial CSB-YP874606LNM
CSB-EP874606LNM
CSB-BP874606LNM
CSB-MP874606LNM
CSB-EP874606LNM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>